Medina, S. R., Tokuyama, N., Putcha, V., Pathak, T., Fu, P., Thomas, H., Subhash, V., Yip, S., Lin, H., Horvath, L., Kench, J. G., Zhang, A. Y., Stockler, M. R., Joshua, A. M., Azad, A., Oakes, S. R., Davis, I. D., Sweeney, C., Madabhushi, A. (2026). An AI-based pathology classifier to predict benefit from enzalutamide in metastatic hormone-sensitive prostate cancer (mHSPC) from ENZAMET (ANZUP 1304).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.108